These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 18344455

  • 21. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM.
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [Abstract] [Full Text] [Related]

  • 22. Telogen effluvium caused by magnesium valproate and lamotrigine.
    Patrizi A, Savoia F, Negosanti F, Posar A, Santucci M, Neri I.
    Acta Derm Venereol; 2005 Feb; 85(1):77-8. PubMed ID: 15849002
    [No Abstract] [Full Text] [Related]

  • 23. Coma probably induced by lorazepam-valproate interaction.
    Lee SA, Lee JK, Heo K.
    Seizure; 2002 Mar; 11(2):124-5. PubMed ID: 11945099
    [Abstract] [Full Text] [Related]

  • 24. Rational polytherapy in the treatment of status epilepticus.
    Walton NY, Treiman DM.
    Epilepsy Res Suppl; 1996 Mar; 11():123-39. PubMed ID: 9294733
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Fatal hepatic necrosis associated with multiple anticonvulsant therapy.
    Smith DW, Cullity GJ, Silberstein EP.
    Aust N Z J Med; 1988 Jun; 18(4):575-81. PubMed ID: 3143348
    [Abstract] [Full Text] [Related]

  • 27. Worsening of negative myoclonus by lamotrigine in a case of idiopathic focal epilepsy of children with long-term follow-up.
    Gélisse P, Genton P, Velizarova R, Serafini A, Crespel A.
    Brain Dev; 2012 Mar; 34(3):248-50. PubMed ID: 21621357
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
    Erickson SC, Le L, Ramsey SD, Solow BK, Zakharyan A, Stockl KM, Harada AS, Curtis B.
    Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ, Rahey SR, Sadler RM.
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [Abstract] [Full Text] [Related]

  • 34. Economic evaluation of anti-epileptic drug therapies with specific focus on teratogenic outcomes.
    Jentink J, Boersma C, de Jong-van den Berg LT, Postma MJ.
    J Med Econ; 2012 Mar; 15(5):862-8. PubMed ID: 22494266
    [Abstract] [Full Text] [Related]

  • 35. Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy.
    Wyllie E, Wyllie R.
    Epilepsia; 1991 Mar; 32 Suppl 5():S74-9. PubMed ID: 1743173
    [Abstract] [Full Text] [Related]

  • 36. Drug interaction between phenytoin and valproic acid in a child with refractory epilepsy: a case report.
    Carvalho IV, Carnevale RC, Visacri MB, Mazzola PG, de Fátima Lopes Ambrósio R, dos Reis MC, de Queiroz RA, Moriel P.
    J Pharm Pract; 2014 Apr; 27(2):214-6. PubMed ID: 24381240
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G, Epifanio G, Auricchio G, Federico RR, Resicato G, Pascotto A.
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [Abstract] [Full Text] [Related]

  • 39. Effect of L-carnitine treatment for valproate-induced hepatotoxicity.
    DeVivo DC.
    Neurology; 2002 Feb 12; 58(3):507-8. PubMed ID: 11839873
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.